Natriuretic peptides: markers or modulators of cardiac hypertrophy? - PubMed (original) (raw)

Review

Natriuretic peptides: markers or modulators of cardiac hypertrophy?

David G Gardner. Trends Endocrinol Metab. 2003 Nov.

Abstract

The natriuretic peptides (NPs), through their diuretic, vasodilatory and anti-mitogenic properties, play an important role in the regulation of cardiovascular, renal and endocrine homeostasis. Recent studies suggest that they have utility in both the diagnosis and management of heart failure. Plasma brain NP (BNP) levels have been used to establish prognosis in patients with heart failure and those at risk for heart failure post-myocardial infarction. They have been used to establish a cardiac etiology for acute shortness of breath, and to guide and assess the efficacy of therapy in patients with established heart failure. BNP is also approved for use in the management of acute decompensated heart failure. Of note, recent studies suggest that cardiac NPs suppress myocyte hypertrophy and interstitial fibrosis in the heart, arguing for an important autocrine-paracrine role of these peptides in controlling the cardiac response during hypertrophy. Therefore, the existing evidence supports a role for BNP as both a marker and a modulator of hypertrophy.

PubMed Disclaimer

Similar articles

• Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
  Abassi Z, Karram T, Ellaham S, Winaver J, Hoffman A. Abassi Z, et al. Pharmacol Ther. 2004 Jun;102(3):223-41. doi: 10.1016/j.pharmthera.2004.04.004. Pharmacol Ther. 2004. PMID: 15246247 Review.
• [Natriuretic peptides: their role in diagnosis and therapy].
  Pakuła D, Marek B, Kajdaniuk D, Kos-Kudła B, Borgiel-Marek H, Krysiak R, Gatnar A, Pakuła P. Pakuła D, et al. Endokrynol Pol. 2007 Jul-Aug;58(4):364-74. Endokrynol Pol. 2007. PMID: 18058731 Review. Polish.
• The role of natriuretic peptides in cardioprotection.
  Nishikimi T, Maeda N, Matsuoka H. Nishikimi T, et al. Cardiovasc Res. 2006 Feb 1;69(2):318-28. doi: 10.1016/j.cardiores.2005.10.001. Epub 2005 Nov 10. Cardiovasc Res. 2006. PMID: 16289003 Review.
• Cardiovascular effects of natriuretic peptides and their interrelation with endothelin-1.
  Han B, Hasin Y. Han B, et al. Cardiovasc Drugs Ther. 2003 Jan;17(1):41-52. doi: 10.1023/a:1024255808831. Cardiovasc Drugs Ther. 2003. PMID: 12843686 Review.
• The endocrine function of the heart.
  McGrath MF, de Bold ML, de Bold AJ. McGrath MF, et al. Trends Endocrinol Metab. 2005 Dec;16(10):469-77. doi: 10.1016/j.tem.2005.10.007. Epub 2005 Nov 2. Trends Endocrinol Metab. 2005. PMID: 16269246 Review.

Cited by

• Endogenous B-type natriuretic peptide: a limb of the regulatory response to acutely decompensated heart failure.
  Hobbs RE, Mills RM. Hobbs RE, et al. Clin Cardiol. 2008 Sep;31(9):407-12. doi: 10.1002/clc.20304. Clin Cardiol. 2008. PMID: 18781599 Free PMC article. Review.
• Impact of obesity on the expression profile of natriuretic peptide system in a rat experimental model.
  Cabiati M, Raucci S, Liistro T, Belcastro E, Prescimone T, Caselli C, Matteucci M, Iozzo P, Mattii L, Giannessi D, Del Ry S. Cabiati M, et al. PLoS One. 2013 Aug 29;8(8):e72959. doi: 10.1371/journal.pone.0072959. eCollection 2013. PLoS One. 2013. PMID: 24009719 Free PMC article.
• Remodeling of the heart in hypertrophy in animal models with myosin essential light chain mutations.
  Kazmierczak K, Yuan CC, Liang J, Huang W, Rojas AI, Szczesna-Cordary D. Kazmierczak K, et al. Front Physiol. 2014 Sep 22;5:353. doi: 10.3389/fphys.2014.00353. eCollection 2014. Front Physiol. 2014. PMID: 25295008 Free PMC article.
• Natriuretic peptides and Forkhead O transcription factors act in a cooperative manner to promote cardiomyocyte cell cycle re-entry in the postnatal mouse heart.
  Ali M, Liccardo D, Cao T, Tian Y. Ali M, et al. BMC Dev Biol. 2021 Feb 3;21(1):6. doi: 10.1186/s12861-020-00236-y. BMC Dev Biol. 2021. PMID: 33530926 Free PMC article.
• Guanylyl cyclase / atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation.
  Pandey KN. Pandey KN. Can J Physiol Pharmacol. 2011 Aug;89(8):557-73. doi: 10.1139/y11-054. Epub 2011 Aug 4. Can J Physiol Pharmacol. 2011. PMID: 21815745 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal